The agency has cited several drugmakers with warning letters, import alerts, and Form 483s for manufacturing lapses ranging from data integrity violations to sterility assurance failures.
The Department of Commerce is investigating the effects on national security of the importation of pharmaceuticals and pharmaceutical ingredients to the U.S.
Joaquin Duato told investors on a Tuesday earnings call that J&J’s “already elevated” U.S. investment levels are the result of the passage of the 2017 Tax Cuts & Jobs Act.
